Clinical Trials on Alzheimer’s Disease (CTAD) 2026
Event Overview
We’re excited to share that Ricoh Biosciences will be attending the Clinical Trials on Alzheimer’s Disease (CTAD) 2026 conference this November in Boston. CTAD is a global forum dedicated exclusively to Alzheimer’s disease clinical research, bringing together investigators, clinicians, industry scientists, and regulatory experts. Connect with our team to explore how our patient-derived iPSC models, disease-relevant functional assays, and collaborative partnership models help bridge the gap between discovery and the clinic, giving Alzheimer’s programs stronger human-relevant data to support confident decisions on the path to clinical trials.
Event Details
Poster Presentation
Join us at our poster to dive deeper into our research:
Alzheimer’s Disease Patient Biology in a Dish
Book a Meeting
Planning to attend CTAD 2026? Request a time to meet our team in Boston, and we’ll connect you with the right experts for your research.